The Role of Support Groups, Advocacy Groups,and Other Interested Parties in Improving the Care of Patients with Congenital Adrenal Hyperplasia: Pleas and Warnings by unknown
Hindawi Publishing Corporation
International Journal of Pediatric Endocrinology
Volume 2010, Article ID 563640, 4 pages
doi:10.1155/2010/563640
Commentary
The Role of Support Groups, Advocacy Groups,and
Other Interested Parties in Improving the Care of Patients
with Congenital Adrenal Hyperplasia: Pleas and Warnings
Peter A. Lee1, 2 and Christopher P. Houk3
1 Department of Pediatrics, Penn State College of Medicine, The Milton S. Hershey Medical Center, P.O. Box 850,
500 University Drive, Hershey, PA 17033-0850, USA
2 Section of Pediatric Endocrinology, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis,
IN 46202, USA
3 Department of Pediatrics, Medical College of Georgia, Augusta, GA 30912, USA
Correspondence should be addressed to Peter A. Lee, leepa@iupui.edu
Received 1 April 2010; Accepted 27 April 2010
Copyright © 2010 P. A. Lee and C. P. Houk. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
In the era of advocacy groups, it seems appropriate to contemplate how best to utilize them for patient benefit in the management
of those with disorders of sex development (DSD), including those with congenital adrenal hyperplasia (CAH). Such interactions,
to be constructive, require a spirit of cooperation to optimize outcomes. A traditional view of advocacy groups as a type of
defender of patients’ rights appears outdated and it is time that the benefits of their participation be fully realized. Open
dialogue with all patients/families, including those who feel harmed by prior care are paramount. We discuss several recent
examples of interactions that illustrate how dialogue in the name of “advocacy” can have a negative impact on developing
a framework for ongoing constructive dialogue and actions. Such approaches completely change the dynamics of subsequent
interactions. Physicians involved in the care of individuals with DSD, including those with CAH, and patients should be aware of
confrontational techniques and legal implications that may be used by some advocacy groups. Hopefully recent eﬀorts to promote
a multidisciplinary care approach for patients with DSD/CAH will continue to foster mutual cooperation between team members,
where the common goal is improving patient/family outcomes and quality of life.
1. Background
It may be appropriate to review the objective of Rotary
International—to encourage and foster the ideal of service as a
basis of worthy enterprise [1]. This involves the development
of opportunities for service, maintenance of high ethical
standards in business and professions, the recognition of the
worthiness of all useful occupations, and the dignifying of
every occupation as an opportunity to serve society. Their
philosophy is expressed in the “Rotarian four-way test” [2],
a type of litmus test used to determine whether a planned
action is compatible with the Rotarian spirit. The questions
posed by the “four-way test” are the following (1) Is it the
truth? (2) Is it fair to all concerned? (3) Will it build goodwill
and better friendships? and (4) Will it be beneficial to all
concerned? The authors submit that such a test would make
a good standard for assessing the actions of support and
advocacy groups involved in obtaining and sustaining the
best care for patients with congenital adrenal hyperplasia
(CAH) and other disorders of sex development (DSD).
In recent decades, there have been many positive changes
toward a more humanistic approach to medical care pro-
vided to patients [3–5]. This has certainly been true for
the person born with CAH, with or without ambiguous
genitalia. This is likewise true for other DSDs. Basic among
these changes are full disclosure of all known medical
information and findings to the patient and their families,
respect for patient privacy with regard to unnecessary
physical exposure during clinical examinations for teaching
purposes, and the inherent right of parents or patients to
make decisions regarding therapy. These include in some
instances gender assignment, after being fully informed of
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the medical and psychological ramifications. We strongly
believe all of these changes pass the four-way Rotarian test.
The community of health care providers has progressively
adopted these approaches.
Optimal care involves a group of well-informed, well-
intentioned, and experienced team members whose primary
goals are to provide all pertinent aspects of medical infor-
mation, the potential therapies, and the advantages and
disadvantages of each. To accomplish this, a team eﬀort
with all participants focusing on the common good of the
patient(s) with a basic respect for other team members’
diﬀering opinions and perspectives is imperative. Support
groups have aided considerably in this eﬀort during recent
years, with a key role for them to advise and counsel newly
diagnosed patients or, in the situation of the newborn,
parents of the neonate. This has at times developed into
a support group representing older patients about their
concerns with their previous medical care. Support groups
such as the MAGIC (Major Aspects of Growth in Children)
Foundation and the CARES (Congenital Adrenal Hyper-
plasia Research Education & Support) Foundation have
provided such needed advice and support, as did the Intersex
Society of North America (ISNA).
Whenever situations involve a change in the standard of
care, as has occurred for those with DSDs, and whenever
there are instances involving strong emotions, there is a high
risk of polarization. All involved must be alert to this and
work to manage and mitigate these risks and biases. It is
tempting to conclude that the potential risk for polarization
is high for support/advocacy groups. These groups are likely
to have a primarily emotional approach to the problem.
When combined with a high degree of zeal to help plus
defensive reactions of interactions with others involved in
helping patients with DSDs, the outcome is less likely to be
constructive. These groups also risk becoming so focused
on one particular aspect of care that they lose sight of the
value of long-term experience or in-depth education about
the multiple ramifications of complex medical conditions.
2. Perspectives
This article is written from the perspective that collaboration
is the most productive approach and confrontation, coercion
and intimidation are likely to be divisive and, in fact, may
undermine any beneficial patient outcome. Confrontational
tactics used by “advocacy” groups have included pressuring
the medical community to adopt narrow mandates, such as
a moratorium on all reproductive system surgery [6], that
cannot apply to the broad range of situations encountered in
practice or the use of accusations regarding therapy received
by patients in the past. These tactics are currently being
employed by well-meaning individuals whose passion for
confrontation seems to cloud the recognition that multiple
factors are involved in patient outcomes, many of which are
beyond the control of the healthcare team. These individuals
may also fail to recognize that prior care was within the
standard of care that existed at the time. Much of this type of
misinterpretation of information and incomplete knowledge
of the topic is a common part of human communications.
Further, as has been noted in other situations of early
childhood (and illustrated below), the patients may not actu-
ally remember the details [7, 8], the timing, or the sequence
of decisions, may confuse personal experiences with those of
others, and may simply lack the knowledge or understanding
for the reasons for the treatment decisions that aﬀected
them. Such recall bias may lead to chronic resentment, which
ultimately can impede lifelong adjustment.
With the recent proliferation of advocacy and support
groups, there are examples of confrontational methods in
attempts to rectify treatments. These are exemplified by: (1)
publication by CARES Foundation [9] of a publication of
the Endocrine Society’s Research Aﬀairs core committee [10]
which reviewed the pros and cons of the prenatal therapy
of at risk fetuses including the conclusion which called for
abandonment of prenatal treatment of CAH; this together
with (2) a group of bioethicists objecting to the use of
prenatal dexamethasone therapy given to pregnant women
at risk of having a 46,XX fetus with CAH, a practice that
may have quickly become too common, illustrating one of
numerous therapies presumed, but not proven, to be safe
[11], that has been adopted without clear FDA approval for
the specific indication, exemplified by the cited example [12];
(3) Advocates for Informed Choice, which on one hand very
appropriately promotes giving pediatric patients a voice in
treatment of DSD [13, 14], while on the other has demanded
apologies from institutions and physicians who cared for
children with DSD in the past and regularly publisher articles
in a nonpeer reviewed, free periodical. These publications
include the statement that gonadectomy in an infant with
DSD is comparable to castrating a mentally retarded child
to preclude fertility [15]. Unfortunately, this style to draw
attention often does not lead to an informed identification
of a problem and can be particularly destructive to the
development of a balanced resolution. Conversely, if parties
from both sides of this issue could have open discussions, an
informed viewpoint that would benefit all involved (Rotarian
rule no. 4) can be promoted.
Such approaches are fraught with the possibility of
misrepresentation and are at risk to result in more harm than
good. The failure to fully explore all aspects of a complex
issue or the alienation of those with years of experience
caring for children with DSDs may be detrimental. In
addition, these types of complaints are typically not based on
a representative survey of patient outcome data. They risk the
possibility that some may aggressively defend the dissatisfied
person without a full knowledge of the uniqueness of that
individual.
An additional problematic aspect of several support
groups is that gay, lesbian, or gender dysphoria has been
added to the list of patients represented. Trying to lump
together multiple types of patients merely based on the
assumption that all are dissatisfied creates the risk of
advocating against therapies that may be uniquely beneficial
for patients with DSDs. While there are aspects where
children with DSDs, transsexual, gay, and lesbian persons
overlap, there are many other areas in which the issues
are substantially diﬀerent. There is a danger that gender
dysfunction aspects will be overly emphasized if DSDs are
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approached like physically normal people with sexual orien-
tation and transsexual concerns. On one hand, those have
gender issues but having been born with fully diﬀerentiated
genitalia can relate very well with those who were born
with genital ambiguity; on the other, a whole spectrum of
other factors may be involved for the person with a DSD
such as the need for surgery, fertility issues, the eﬀect of
having “diﬀerent” genitalia, or the need for chronic medical
management.
To be constructive, support groups should begin to
view the controversial issues in DSD management from
broader perspectives that can be focused on areas of need.
These include approaching (1) parents at the birth of
a child with CAH or DSD, (2) approaching the child
and parent as the child matures and becomes able to
understandhis\her condition and to assume responsibility
for decisions regardinghis\her care, and (3) reviewing the
ongoing needs of adult patients who may feel that previous
standard of care treatments were done with a malicious or
callous intent.
3. Recall Fallacies
It is known that recall of specifics from early childhood
traumatic situations may be inaccurate [7, 8]. By citing
information below from three patients born with genital
ambiguity, two of whom have CAH, it is shown that the
individuals’ knowledge of decisions and disclosure during
infancy and childhood were misremembered and further
shown how advocacy groups criticized former caregivers
inappropriately. These accusations did little to enhance
adjustment for the patient to improve future care. Patient’s
inaccurate memories from childhood events may result from
confusing what parents said or from refusing to discuss
unclear memories of stressful or traumatic experiences.
Patient no. 1 was diagnosed with 21-hydroxylase deficient
CAH in the neonatal period and had feminizing genital
surgery as an infant. She was compliant with medical therapy
and had normal growth and pubertal development. Her
medical records show that from late childhood, her routine
visits included a discussion of CAH, its diagnosis, therapy,
consequences, and outcome. She required vaginoplasty while
a late teenager to permit sexual intercourse. As a late
teenager, she realized for the first time the impact of her
condition, including the medical and surgical therapy, on
her sexuality because of the diminished genital sensitivity
and the risk of subfertility. Using a support group lawyer,
this patient accused her primary CAH caregiver, a pediatric
endocrinologist, of having never explained her condition
and its potential consequences to her. The contact person
in the support group was very careful not to accuse the
endocrinologist, while the patient appeared to blame the
potential consequences of her underlying condition on her
endocrinologist. An attempt was made to give the patient
a perspective that there is no perfect therapy for CAH, and
her physician had tried to make her aware of the possible
consequences.
Patient #2 has a diagnosis of 46,XY DSD and was born
during the time period when the female gender assignment
was commonly recommended for those with an unclear
etiologic diagnosis and a phallus judged to be inadequate
for intercourse. She was given a female sex assignment, and
surgery was done in infancy to align with a female sex of
rearing. The patient’s mother indicated that she felt forced
into the assignment, and in fact the medical record does
not contain documentation of parental agreement with this
decision. Throughout childhood, it was apparent that the
mother, who accompanied the patient during clinic visits,
had not fully accepted the female sex of rearing. Counseling
was recommended and accepted by both the patient and the
mother. However, the situation became worse during the
teen years. Many of her problems appeared to stem from
the situation in which her mother confided in other local
mothers information about her daughter having been born
with a very small penis, and so she was changed to a girl.
As a consequence, her school peers of both sexes learned
this information and teased her mercilessly. Faced with a
degree of distress with which she did not know how to cope,
this person has repeatedly accused her long-time caregiver,
who assumed her medical care at age 6 years, of harmful
medical treatment. In spite of providing this individual with
medical records, accusations have continued that have been
supported by her advocacy group. Such an unsatisfactory
situation would hopefully be an opportunity for a support
group to counsel and care for this patient to help her
develop a perspective that her previous physicians had done
what seemed best for her at the time. Unfortunately, she
remains poorly adjusted, in need of helpful counseling
having alienated a caregiver whose only intention was to help
her.
Patient no. 3, is now in her 40s, was a 46,XX patient
who was initially assigned a male sex of rearing because
of masculinized genitalia. At one month of age, after the
diagnosis of CAH was made, she was reassigned female.
At several years of age, care was transferred to a university
aﬃliated hospital having a large pediatric endocrine unit.
One endocrinologist subsequently assumed her primary
endocrine care at age 14 years. At this time, she was a very
attractive female, with normal weight and height for age, who
was having regular menses. In fact, she was told how well
she was doing. Subsequently she has said that she did not
understand, if she was doing so well, why she had to continue
to have regular doctor visits. She was unwilling or unable to
accept the fact that she had a condition which would require
lifelong monitoring and therapy adjustments. It became
obvious while this patient was a teen that she had not
adjusted well and that counseling was needed and began. She
married and had severe sexual problems. She subsequently
indicated to her previous caregiver that she had numerous
problems because of CAH and its therapy, the primary one
being sexual. Again counseling was recommended. More
recently an advocacy group, on her behalf, initially contacted
the hospital where she was cared for from early childhood
through adolescence. The communication, consisting of a
letter and regular-emails, demanded an apology for her
previous care as a way of opening a dialogue to foster healing.
These communications were forwarded to the hospital’s
legal department, where, after repeated demands for an
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apology, it was decided that a letter of apology be sent
to recognize that harm may have occurred as a result of
her then standard of care treatments. This letter was sent,
even though the primary complaints were against the care
during early infancy, before care was transferred to this
hospital. Shortly thereafter, a similar legal advocacy letter
was written to the physician who provided her pediatric
endocrine care after age 14 years also demanding an apology
for her care including nondisclosure, excessive examination
room exposure to training physicians, and excessive genital
examinations. In fact, these practices had changed prior to
this physician assuming her care. In response to continued
requests, a letter of apology was written even though legal
advice indicated that there was no legal reason to do so
and in spite of the perspective that it would do little to
foster psychological adjustment. The letter was accompanied
with an oﬀer by the physician to discuss these issues directly
with the patient. Subsequent to these two letters, a similar
letter was written to the hospital where this person was
initially treated as an infant. It would be hoped that with
skillful counseling that this patient could have been spared
the on-going psychological pain, with the former caregiver
being part of the solution rather than the scapegoat of the
problems.
4. A Constructive Approach
The care of individuals with CAH and other DSDs has
evolved dramatically over the last two decades [16] and will
likely evolve further as the team approach improves and
refines management of those with such complicated and rare
disorders. The changes have resulted from the realization of
previous misconceptions about the determinants of gender
identity, the assumption that sex of rearing can always over-
ride other determinants of gender identity, an appreciation of
the impact of fetal androgen exposure, the recognition of the
importance of adult female sexual responsiveness, and new
methodologies to improve fertility potential.
This communication is a global plea for open and
constructive communication among all members of the
care team: the patient, the family, the practitioner and the
support/advocacy group in the singular goal of improving
patient outcomes. Not only should the traditional members
of the multidisciplinary team caring for individuals with
CAH and DSDs faithfully follow the Rotarian four-way test,
but we, the authors, would submit that the newer members
of the global approach, the support/advocacy groups, should
also see this as a charter intended to improve patient
outcomes, a goal upon which we can all agree.
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